| Financial Year |
March 31 2023 |
| Monetary Funds |
515,472,408.35 |
| Held-for-trading Financial Assets |
275,569,452.45 |
| Notes Receivable |
6,390,268.23 |
| Accounts Receivable |
437,556,761.79 |
| Advances to Suppliers |
6,508,401.22 |
| Other Receivables |
3,933,096.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
38,004,352.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
11,770,938.52 |
| Other Current Assets |
4,458,976.48 |
| Total Current Assets |
1,306,200,106.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
32,547,382.68 |
| Long-term Equity Investment |
56,599,440.38 |
| Investment Properties |
-- |
| Fixed Assetes |
197,513,926.95 |
| Under-construction Projects |
2,976,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,494,650.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,475,686.14 |
| Deferred Income Tax Assets |
6,584,060.39 |
| Other Non-Current Assets |
12,884,143.57 |
| Sub-Total of Non-Current Assets |
365,221,844.95 |
| Total Assets |
1,671,421,950.98 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,196,169.51 |
| Accounts Received In Advance |
595,837.52 |
| Employee Compensation Payable |
20,109,425.95 |
| Taxes Payable |
7,155,061.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,846,129.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,753,527.43 |
| Other Current Liabilities |
50,655.19 |
| Sub-Total of Current Liabilities |
64,782,610.08 |
| Long-term Loans |
46,640,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
850,267.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
61,912,805.77 |
| Total Liabilities |
126,695,415.85 |
| Paid-In Capital(Or Share Stock) |
398,156,535.00 |
| Capital Surplus |
270,376,205.67 |
| Surplus Reserve |
101,770,579.68 |
| LESS:Treasury Stock |
112,029,472.65 |
| Undistributed Profits |
884,729,476.12 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,544,726,535.13 |
| Owner's Equity（Stockholder's Equity） |
1,544,726,535.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,671,421,950.98 |
